You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Hepatocellular Carcinoma Trial in Tianjin (Sintilimab, Bevacizumab, Liver Protective Support Therapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 8, 2022

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Aug 22, 2022

Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Rennes, France
    Centre Eugene Marquis
Jan 16, 2023

Unresectable Hepatocellular Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Chicago, Illinois
  • +6 more
Jan 18, 2023

Hepatocellular Carcinoma, Cirrhosis Trial in Falls Church (Namenda)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Cirrhosis
  • Falls Church, Virginia
    Inova Health Care Service
Aug 18, 2023

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Unresectable Hepatocellular Carcinoma Trial (Donafenib plus Sintilimab in combination with transarterial chemoembolisation)

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Donafenib plus Sintilimab in combination with transarterial chemoembolisation
  • (no location specified)
Aug 17, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Hepatocellular Carcinoma, Cirrhosis Trial in Worldwide (Namodenoson, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Cirrhosis
  • Banja Luka, Bosnia and Herzegovina
  • +24 more
Jun 27, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Hepatocellular Cancer Trial in Phoenix, Chicago, Winston-Salem (device, drug, other)

Recruiting
  • Hepatocellular Cancer
  • TheraBionic Device
  • +2 more
  • Tampa, Florida
  • +6 more
Dec 12, 2022

Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Resin microspheres containing yttrium-90 (Y-90)
  • Mission Hills, California
  • +15 more
Sep 15, 2022

Child-Pugh Class A, Child-Pugh Class B, Stage IIIA Hepatocellular Carcinoma Trial in Columbus (other, radiation, procedure)

Completed
  • Child-Pugh Class A
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 5, 2021

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +9 more
  • Durvalumab
  • Tremelimumab
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Not yet recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Miami, Florida
  • +4 more
Aug 23, 2022

Carcinoma, Hepatocellular Trial in France (Idarubicin and Lipiodol)

Recruiting
  • Carcinoma, Hepatocellular
  • Idarubicin and Lipiodol
  • Angers, France
  • +3 more
Dec 24, 2021

Under Real-world Practice Conditions, Safety and Effectiveness

Completed
  • Liver Neoplasms
  • Regorafenib (Stivarga, BAY73-4506)
  • Gilbert, Arizona
  • +36 more
Jul 26, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
  • +46 more
May 22, 2023

Tolerability of Lenvatinib in Advanced or Unresectable

Recruiting
  • Carcinoma, Hepatocellular
  • Clovis, California
  • +48 more
Aug 12, 2022

Hepatocellular Carcinoma Trial in Worldwide (CF102, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Aurora, Colorado
  • +20 more
Mar 7, 2022

Donafenib Combined With TACE-based Treatment in Unresectable HCC

Recruiting
  • Hepatocellular Carcinoma
  • Donafenib
  • Donafenib combined with TACE
  • Shanghai, China
    Fudan University
Mar 21, 2022